Hofmeyer Kimberly A, Jeon Hyungjun, Zang Xingxing
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
J Biomed Biotechnol. 2011;2011:451694. doi: 10.1155/2011/451694. Epub 2011 Sep 25.
Cytotoxic CD8 T lymphocytes (CTLs) play a pivotal role in the control of infection. Activated CTLs, however, often lose effector function during chronic infection. PD-1 receptor and its ligand PD-L1 of the B7/CD28 family function as a T cell coinhibitory pathway and are emerging as major regulators converting effector CTLs into exhausted CTLs during chronic infection with human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and other pathogens capable of establishing chronic infections. Importantly, blockade of the PD-1/PD-L1 pathway is able to restore functional capabilities to exhausted CTLs and early clinical trials have shown promise. Further research will reveal how chronic infection induces upregulation of PD-1 on CTLs and PD-L1 on antigen-presenting cells and other tissue cells and how the PD-1/PD-L1 interaction promotes CTLs exhaustion, which is crucial for developing effective prophylactic and therapeutic vaccination against chronic infections.
细胞毒性CD8 T淋巴细胞(CTL)在感染控制中起关键作用。然而,活化的CTL在慢性感染期间常常丧失效应功能。B7/CD28家族的程序性死亡蛋白1(PD-1)受体及其配体程序性死亡配体1(PD-L1)作为T细胞共抑制途径发挥作用,并且在人类免疫缺陷病毒、乙型肝炎病毒、丙型肝炎病毒以及其他能够建立慢性感染的病原体的慢性感染过程中,正逐渐成为将效应CTL转化为耗竭CTL的主要调节因子。重要的是,阻断PD-1/PD-L1途径能够恢复耗竭CTL的功能能力,并且早期临床试验已显示出前景。进一步的研究将揭示慢性感染如何诱导CTL上PD-1以及抗原呈递细胞和其他组织细胞上PD-L1的上调,以及PD-1/PD-L1相互作用如何促进CTL耗竭,这对于开发针对慢性感染的有效预防性和治疗性疫苗至关重要。